Request Deal Involvement

WACKER completed the acquisition of ADL BioPharma from Kartesia for €100m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

CMS

legal advisors

CMS

Grant Thornton

accounting advisors

Grant Thornton

Linklaters

legal advisors

Linklaters

or

Principals

ADL BIOPHARMA

target

ADL BIOPHARMA

WACKER CHEMIE AG

bidder

WACKER CHEMIE AG

KARTESIA

vendor

KARTESIA

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - WACKER completed the acquisition of ADL BioPharma from Kartesia for €100m.